1-4 of 4
Anna Pawlowska, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Geoff D.E. Cuvelier, MD, Amina Kariminia, PhD, Eneida R. Nemecek, MDMBA,MSc, Carrie Kitko, MD, Justin T. Wahlstrom, MD, Andrew C Harris, MD, Henrique Bittencourt, MD PhD, Victor A. Lewis, MD, Michael A Pulsipher, MD, Tal Schechter-Finkelstein, MD, Sung W. Choi, MD, Emi Caywood, MD, Monica Bhatia, MD, Kimberly A. Kasow, DO, David Jacobsohn, MD, Benjamin Oshrine, MD, Sonali Chaudhury, MD, Joseph H. Chewning, MD, Flower Allyson, MD, Don W. Coulter, MD, Michael J. Joyce, MD, Sureyya Savasan, MD, Anna Pawlowska, MD, Gail Megason, MD, David Mitchell, MD, Alexandra Cheerva, MD, Anita Lawitschka, MD, Bernard Ng, PhD, Kirk R. Schultz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-139031
Published: 2020
Journal Articles

Pilot Study: Favorable Outcomes with Addition of Topotecan to Busulfan/Melphalan As High-Dose Myeloablative Therapy Followed by Autologous Hematopoietic Cell Transplantation

Joseph Rosenthal, MD, Anna Pawlowska, MD, Jerry Cheng, MD, Steven Kechichian, Debbie Hitt, Mary Suarez, Ni-Chun Tsai, MS MPH, Joycelynne Palmer, PHD
Journal: Blood
Blood (2012) 120 (21): 4553.
https://doi.org/10.1182/blood.V120.21.4553.4553
Published: 2012
Journal Articles

Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).

Joseph Rosenthal, MD, Anna Pawlowska, MD, Ellen Bolotin, MD, PhD, Peter Falk, MD, Cheryl Oliver, RN, Stephen Forman, MD
Journal: Blood
Blood (2007) 110 (11): 4943.
https://doi.org/10.1182/blood.V110.11.4943.4943
Published: 2007
Journal Articles

Augmenting the Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) by Addition of Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy in Patients (pts) with Advanced Hematological Malignancies.

Joseph Rosenthal, MD, Jeffrey Wong, MD, Anthony Stein, MD, Ellen Bolotin, MD, PhD, Chatchada Karanes, MD, Leslie Popplwell, MD, Auayporn Nademanee, MD, Firoozeh Sahebi, MD, Margaret O’Donnell, MD, Maria Delioukina, MD, George Somlo, MD, Anna Pawlowska, MD, Debbie Hitt, RN, Marianna Shakhnovits, MD, Stephen Forman, MD
Journal: Blood
Blood (2007) 110 (11): 3021.
https://doi.org/10.1182/blood.V110.11.3021.3021
Published: 2007